Park, J.Y.; Chae, J.R.; Cho, Y.L.; Kim, Y.; Lee, D.; Lee, J.K.; Kang, W.J.
Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer. Pharmaceutics 2020, 12, 985.
https://doi.org/10.3390/pharmaceutics12100985
AMA Style
Park JY, Chae JR, Cho YL, Kim Y, Lee D, Lee JK, Kang WJ.
Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer. Pharmaceutics. 2020; 12(10):985.
https://doi.org/10.3390/pharmaceutics12100985
Chicago/Turabian Style
Park, Jun Young, Ju Ri Chae, Ye Lim Cho, Youndong Kim, Dasom Lee, Jeong Kyun Lee, and Won Jun Kang.
2020. "Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer" Pharmaceutics 12, no. 10: 985.
https://doi.org/10.3390/pharmaceutics12100985
APA Style
Park, J. Y., Chae, J. R., Cho, Y. L., Kim, Y., Lee, D., Lee, J. K., & Kang, W. J.
(2020). Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer. Pharmaceutics, 12(10), 985.
https://doi.org/10.3390/pharmaceutics12100985